These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34992271)

  • 1. Conditional immortalization of human atrial myocytes for the generation of in vitro models of atrial fibrillation.
    Harlaar N; Dekker SO; Zhang J; Snabel RR; Veldkamp MW; Verkerk AO; Fabres CC; Schwach V; Lerink LJS; Rivaud MR; Mulder AA; Corver WE; Goumans MJTH; Dobrev D; Klautz RJM; Schalij MJ; Veenstra GJC; Passier R; van Brakel TJ; Pijnappels DA; de Vries AAF
    Nat Biomed Eng; 2022 Apr; 6(4):389-402. PubMed ID: 34992271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K
    Schmidt C; Wiedmann F; Beyersdorf C; Zhao Z; El-Battrawy I; Lan H; Szabo G; Li X; Lang S; Korkmaz-Icöz S; Rapti K; Jungmann A; Ratte A; Müller OJ; Karck M; Seemann G; Akin I; Borggrefe M; Zhou XB; Katus HA; Thomas D
    Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007465. PubMed ID: 31514528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and primary characterization of iAM-1, a versatile new line of conditionally immortalized atrial myocytes with preserved cardiomyogenic differentiation capacity.
    Liu J; Volkers L; Jangsangthong W; Bart CI; Engels MC; Zhou G; Schalij MJ; Ypey DL; Pijnappels DA; de Vries AAF
    Cardiovasc Res; 2018 Dec; 114(14):1848-1859. PubMed ID: 29917042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AZD1305 exerts atrial predominant electrophysiological actions and is effective in suppressing atrial fibrillation and preventing its reinduction in the dog.
    Burashnikov A; Zygmunt AC; Di Diego JM; Linhardt G; Carlsson L; Antzelevitch C
    J Cardiovasc Pharmacol; 2010 Jul; 56(1):80-90. PubMed ID: 20386458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological characterization and antiarrhythmic efficacy of the mixed potassium channel-blocking antiarrhythmic agent AZ13395438 in vitro and in vivo.
    Jacobson I; Duker G; Florentzson M; Linhardt G; Lindhardt E; Nordkam AK; Åstrand A; Carlsson L
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):290-300. PubMed ID: 23307834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Populations of in silico myocytes and tissues reveal synergy of multiatrial-predominant K
    Ni H; Fogli Iseppe A; Giles WR; Narayan SM; Zhang H; Edwards AG; Morotti S; Grandi E
    Br J Pharmacol; 2020 Oct; 177(19):4497-4515. PubMed ID: 32667679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late Sodium Current in Atrial Cardiomyocytes Contributes to the Induced and Spontaneous Atrial Fibrillation in Rabbit Hearts.
    Chu Y; Yang Q; Ren L; Yu S; Liu Z; Chen Y; Wei X; Huang S; Song L; Zhang P; Ma J; Wu L
    J Cardiovasc Pharmacol; 2020 Oct; 76(4):437-444. PubMed ID: 32675747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic inhibition of small-conductance calcium-activated potassium (SK) channels by NS8593 reveals atrial antiarrhythmic potential in horses.
    Haugaard MM; Hesselkilde EZ; Pehrson S; Carstensen H; Flethøj M; Præstegaard KF; Sørensen US; Diness JG; Grunnet M; Buhl R; Jespersen T
    Heart Rhythm; 2015 Apr; 12(4):825-35. PubMed ID: 25542425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced activity of inositol-1,4,5-trisphosphate receptors in atrial myocytes of atrial fibrillation patients.
    Liang X; Xie H; Zhu PH; Hu J; Zhao Q; Wang CS; Yang C
    Cardiology; 2009; 114(3):180-91. PubMed ID: 19602879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic TWIK-Related Acid-Sensitive K+ Channel (TASK-1) Potassium Channel Inhibitor A293 Facilitates Acute Cardioversion of Paroxysmal Atrial Fibrillation in a Porcine Large Animal Model.
    Wiedmann F; Beyersdorf C; Zhou X; Büscher A; Kraft M; Nietfeld J; Walz TP; Unger LA; Loewe A; Schmack B; Ruhparwar A; Karck M; Thomas D; Borggrefe M; Seemann G; Katus HA; Schmidt C
    J Am Heart Assoc; 2020 May; 9(10):e015751. PubMed ID: 32390491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk between macrophages and atrial myocytes in atrial fibrillation.
    Sun Z; Zhou D; Xie X; Wang S; Wang Z; Zhao W; Xu H; Zheng L
    Basic Res Cardiol; 2016 Nov; 111(6):63. PubMed ID: 27660282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic drug therapy for atrial fibrillation: focus on atrial selectivity and safety.
    Li D; Sun H; Levesque P
    Cardiovasc Hematol Agents Med Chem; 2009 Jan; 7(1):64-75. PubMed ID: 19149545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic and cardiac electrophysiological effects of SZV-270, a novel compound with combined Class I/B and Class III effects, in rabbits and dogs.
    Varga RS; Hornyik T; Husti Z; Kohajda Z; Krajsovszky G; Nagy N; Jost N; Virág L; Tálosi L; Mátyus P; Varró A; Baczkó I
    Can J Physiol Pharmacol; 2021 Jan; 99(1):89-101. PubMed ID: 32970956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization.
    Singh BN; Mody FV; Lopez B; Sarma JS
    Am J Cardiol; 1999 Nov; 84(9A):161R-173R. PubMed ID: 10568677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory role of cardiomyocyte metabolism via AMPK activation in modulating atrial structural, contractile, and electrical properties following atrial fibrillation.
    Brown SM; Larsen NK; Thankam FG; Agrawal DK
    Can J Physiol Pharmacol; 2021 Jan; 99(1):36-41. PubMed ID: 33049144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ryanodine receptor cluster fragmentation and redistribution in persistent atrial fibrillation enhance calcium release.
    Macquaide N; Tuan HT; Hotta J; Sempels W; Lenaerts I; Holemans P; Hofkens J; Jafri MS; Willems R; Sipido KR
    Cardiovasc Res; 2015 Dec; 108(3):387-98. PubMed ID: 26490742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive assessment of fibrillatory activity in patients with paroxysmal and persistent atrial fibrillation using the Holter ECG.
    Bollmann A; Sonne K; Esperer HD; Toepffer I; Langberg JJ; Klein HU
    Cardiovasc Res; 1999 Oct; 44(1):60-6. PubMed ID: 10615390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased ATP-sensitive K(+) current density during chronic human atrial fibrillation.
    Balana B; Dobrev D; Wettwer E; Christ T; Knaut M; Ravens U
    J Mol Cell Cardiol; 2003 Dec; 35(12):1399-405. PubMed ID: 14654366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Na+-channel blockade on the three-dimensional substrate of atrial fibrillation in a model of endo-epicardial dissociation and transmural conduction.
    Gharaviri A; Verheule S; Eckstein J; Potse M; Krause R; Auricchio A; Kuijpers NHL; Schotten U
    Europace; 2018 Nov; 20(suppl_3):iii69-iii76. PubMed ID: 30476060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Small Conductance Calcium-Activated Potassium Channel Inhibitors NS8593 and UCL1684 Prevent the Development of Atrial Fibrillation Through Atrial-Selective Inhibition of Sodium Channel Activity.
    Burashnikov A; Barajas-Martinez H; Hu D; Robinson VM; Grunnet M; Antzelevitch C
    J Cardiovasc Pharmacol; 2020 Aug; 76(2):164-172. PubMed ID: 32453071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.